Herantis Pharma Oyj Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 24, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	57	31	32	28	27	40
Market Cap Growth	65.08%	-3.81%	13.79%	4.72%	-34.19%	-21.79%
Enterprise Value	52	27	31	25	26	39
Last Close Price	2.19	1.51	1.57	1.65	2.28	3.95
PE Ratio	-	-	113.47	-	-	-
Forward PE	-	-	-	-	-	1.42
PB Ratio	32.47	-125.74	6.72	-462.92	-23.37	5.34
P/TBV Ratio	32.47	-	6.72	-	-	5.34
EV/EBIT Ratio	-	-	203.31	-	-	-
Debt / Equity Ratio	0.01	-0.30	0.01	-75.33	-6.43	0.95
Net Debt / Equity Ratio	-2.59	8.48	-1.36	24.05	0.08	-0.81
Net Debt / EBITDA Ratio	-	-	-	0.18	0.01	0.86
Net Debt / FCF Ratio	0.66	0.32	1.39	0.16	0.01	0.72
Quick Ratio	7.47	4.01	3.38	3.26	2.89	4.67
Current Ratio	8.10	4.06	3.39	3.28	2.91	4.68
Return on Equity (ROE)	-287.85%	-220.33%	12.00%	-	-396.06%	-193.95%
Return on Assets (ROA)	-74.56%	-67.44%	1.49%	-71.39%	-64.41%	-36.70%
Return on Capital Employed (ROCE)	-116.60%	-259.40%	3.20%	-184.60%	-242.00%	-59.70%
Earnings Yield	-9.60%	-16.17%	0.88%	-33.41%	-47.91%	-22.60%
FCF Yield	-	-21.43%	-14.60%	-32.05%	-37.28%	-21.14%
Buyback Yield / Dilution	-17.58%	-17.25%	-17.34%	-43.59%	-38.03%	-26.51%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.